|
Institute of Medicine, Food and Nutrition Board
Workshop
"Development of DRIs, 1994-2004: Lessons Learned and New Challenges"
Washington, DC
September 18-20, 2007
DAY 1-September 18
INTRODUCTION
8:30-9:00 Welcome and Opening Remarks
John Suttie, Chair, University of Wisconsin
*View Slides (pdf) *Listen to Opening Remarks
9:00-9:30 Overview of Current DRI Framework and Issues Raised
Christine Taylor, Institute of Medicine
*View Slides (pdf) *Listen to Presentation
SESSION 1
CONCEPTUAL FRAMEWORK FOR DRI DEVELOPMENT
Moderator: Stephanie Atkinson, McMaster University
10:00-10:40 Current Framework for DRI Development: What Are the Pros and Cons?
Robert Russell, Tufts University
*View Slides (pdf) *Listen to Presentation
10:40-10:55 Case Study: Applying the DRI Framework to Chronic Disease Endpoints
Paula Trumbo, Center for Food Safety and Applied Nutrition, FDA
*View Slides (pdf) *Listen to Presentation
10:55-11:10 Case Study: Applying the DRI Framework to Non-chronic Disease Endpoints
Allison Yates, Agricultural Research Service, USDA
*View Slides (pdf) *Listen to Presentation
11:10-11:50 Discussion - Framework Pros/Cons; Case Studies
Co-discussants: Patsy Brannon, Cornell University
Alice Lichtenstein, Tufts University
*Listen to Discussion
11:50-12:20 Two Perspectives: The DRI Framework
Perspective: George Beaton, University of Toronto
*View Slides (pdf) *Listen to Presentation
Perspective: Janet King, University of California, Berkeley and Davis
*View Slides (pdf) *Listen to Presentation
1:30-1:45 Evaluating Evidence for DRI Development: What Are the Issues In Applying Systematic Evidence- Based Review Approaches to DRI Development?
Alice Lichtenstein, Tufts University
*View Slides (pdf) *Listen to Presentation
1:45-2:15 Risk Assessment: Is It a Relevant Organizing Structure?
Elizabeth Yetley, Office of Dietary Supplements, NIH
*View Slides (pdf) *Listen to Presentation
2:15-2:55 Discussion - Systematic Evidence Based Review; Risk Assessment
Discussant: Sanford Miller, University of Maryland
*Listen to Discussion
2:35-2:55 Discussion open to all attendees
*Listen to Q&A Discussion
3:15-5:15 Panel Discussion 1 – In What Ways Could the Conceptual Framework Be Enhanced?
Panel Members: Cutberto Garza, Boston College
Mary L'Abbe, Health Canada
Irwin Rosenberg, Tufts University
Barbara Stoecker, Oklahoma State University
*Listen to Panel Discussion
4:00-5:15 Discussion open to all attendees
*Listen to Q&A Discussion
DAY 2-September 19
SESSION 2
CRITERIA FOR SCIENTIFIC DECISION-MAKING
Moderator: Robert Russell, Tufts University
8:30-8:50 am Selecting Endpoints: What Are the Issues and What Are the Options for Criteria?
Irwin Rosenberg, Tufts University
*View Slides (pdf) *Listen to Presentation
8:50-9:00 Discussion
*Listen to Discussion
9:00-9:15 Dose-Response Data: Are There Options for Dealing with Limited Data?
Susan Mayne, Yale School of Public Health
*View Slides (pdf) *Listen to Presentation
9:15-9:30 Discussion
*Listen to Discussion
9:30-9:45 Challenges in Addressing Extrapolation/Interpolation for
Unstudied Groups
Stephanie Atkinson, McMaster University
*View Slides (pdf) *Listen to Presentation
9:45-10:00 Discussion
*Listen to Discussion
10:30-10:45 What Are the Challenges in Addressing Adjustment for Data Uncertainty?
Hildegard Przyrembel, Federal Institute for Risk Assessment, Berlin, Germany
*View Slides (pdf) *Listen to Presentation
10:45-11:00 Discussion
*Listen to Discussion
11:00-11:20 Estimating Dietary Intake: What are the Implications for DRI Development?
Amy Subar, National Cancer Institute, NIH
*View Slides (pdf) *Listen to Presentation
11:20-11:30 Discussion
*Listen to Discussion
11:30-11:45 Highlights of Other Important Issues: Physiological, Genomic and Environmental Factors
Cutberto Garza, Boston College
*View Slides (pdf) *Listen to Presentation
11:45-12:00 Discussion
*Listen to Discussion
SESSION 3
GENERAL GUIDANCE FOR USERS OF DRIs
Moderator: Mary Bush, Health Canada
1:00-1:20 pm Overview: Issues Raised About General Guidance for Users
Christine Taylor, Food and Nutrition Board, Institute of Medicine
*View Slides (pdf) *Listen to Presentation
1:20-1:40 Discussion--- Discussant: Johanna Dwyer, Office of Dietary Supplements, NIH
*Listen to Discussion
1:30-1:40 Discussion open to all attendees
*Listen to Discussion
1:40-2:05 Special Challenges: Planning and Assessing the Total Diet- What are the Issues and
What are the Options for Enhanced Guidance?
Suzanne Murphy, University of Hawaii
*View Slides (pdf) *Listen to Presentation
Susan Barr, University of British Columbia
*View Slides (pdf) *Listen to Presentation
2:05-2:30 Discussion--- Co-discussants: Patricia Guenther, Ctr for Nutr Policy & Promotion USDA
Krista Esslinger, Health Canada
*Listen to Discussion
2:20-2:30 Discussion open to all attendees
*Listen to Discussion
2:45-3:10 Special Challenges: What are the Issues Related to a Framework for Individual-level and
Group-level Applications?
Valerie Tarasuk, University of Toronto
*View Slides (pdf) *Listen to Presentation
3:10-3:30 Discussion--- Discussant: Gerard Dallal, Tufts University
*Listen to Discussion
3:20-3:30 Discussion open to all attendees
*Listen to Q&A Discussion
3:30-5:15 Panel Discussion 2 – In What Ways Could the Guidance for Users of DRIs Be Enhanced?
Panel Members: Danielle Brulé, Health Canada
Mary Frances Picciano Office of Dietary Supplements, NIH
William Rand, Tufts University School of Medicine
Linda Van Horn, Northwestern University
*Listen to Panel Discussion
DAY 3-September 20
SESSION 4
LOOKING TO THE FUTURE PROCESS FOR DRI DEVELOPMENT
Moderator: Paul Coates, Office of Dietary Supplements, NIH
8:30-8:45 am Emerging Issues: What New Challenges Might the Future Hold?
Catherine Woteki, Mars Inc.
*View Slides (pdf) *Listen to Presentation
8:45-8:55 Discussion
*Listen to Discussion
8:55-9:10 Is There a Need to Enhance Transparency of Decision-Making Process?
Robert Russell, Tufts University
*View Slides (pdf) *Listen to Presentation
9:10-9:20 Discussion
*Listen to Discussion
9:20-9:35 IOM Overview of Options for Stakeholder Input
Linda D. Meyers, Food and Nutrition Board, Institute of Medicine
*View Slides (pdf) *Listen to Presentation
9:35-9:45 Discussion
*Listen to Discussion
9:45-10:00 What are the Options for Criteria for Determining When to Update/Review Existing DRIs?
John Suttie, Chair, University of Wisconsin
*View Slides (pdf) *Listen to Presentation
10:10-10:25 What Are the Considerations in Specifying “New” Nutrient Substances for DRI Study?
Peter Greenwald, National Cancer Institute, NIH
*View Slides (pdf) *Listen to Presentation
10:25-10:35 Discussion
*Listen to Discussion
10:50-12:45 Panel Discussion 3 – Reflections on What We Have Heard About the Process of DRI Development
Panel Members: Mary Bush, Health Canada
Jean-Pierre Habicht, Cornell University
Suzie Harris, ILSI Research Foundation
Van Hubbard, Div of Nutrition Research Coordination, NIH
Molly Kretsch, Agricultural Research Service, USDA
*Listen to Panel Discussion
11:50-12:45 Discussion open to all attendees
*Listen to Q&A Discussion
12:45-1:15 Summary and Closing Remarks
Chair's Summary (John Suttie)
Closing Remarks from Sponsor Representative (Paul Coates)
Chair's Close of Workshop
*Listen to Summary and Closing Remarks
|